Financial Ratios

KOPRAN LTD.

NSE : KOPRANBSE : 524280ISIN CODE : INE082A01010Industry : Pharmaceuticals & DrugsHouse : Parijat
BSE258.4011.4 (+4.62 %)
PREV CLOSE ( ) 247.00
OPEN PRICE ( ) 249.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20721
TODAY'S LOW / HIGH ( )249.30 263.85
52 WK LOW / HIGH ( )96.8 292.4
NSE258.6011.25 (+4.55 %)
PREV CLOSE( ) 247.35
OPEN PRICE ( ) 247.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 258.60 (458)
VOLUME 446183
TODAY'S LOW / HIGH( ) 247.40 264.00
52 WK LOW / HIGH ( )98.05 292.3
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)6.482.445.432.593.00
   CEPS(Rs)7.403.336.383.403.72
   DPS(Rs)3.003.001.500.000.00
   Book NAV/Share(Rs)82.0578.5657.0753.1050.51
   Tax Rate(%)15.3427.3428.2328.6825.27
Margin Ratios
   Core EBITDA Margin(%)10.227.4613.5312.9211.53
   EBIT Margin(%)14.499.3416.3812.0911.59
   Pre Tax Margin(%)13.517.9014.678.778.82
   PAT Margin (%)11.445.7410.536.266.59
   Cash Profit Margin (%)13.067.8512.378.198.17
Performance Ratios
   ROA(%)6.442.987.223.504.24
   ROE(%)8.073.759.855.016.12
   ROCE(%)9.445.6413.577.988.67
   Asset Turnover(x)0.560.520.690.560.64
   Sales/Fixed Asset(x)3.883.093.703.344.09
   Working Capital/Sales(x)3.052.735.245.916.03
Efficiency Ratios
   Fixed Capital/Sales(x)0.260.320.270.300.24
   Receivable days95.5096.8775.2788.5960.00
   Inventory Days59.5361.5656.2267.5250.94
   Payable days107.49119.02105.86133.73109.18
Valuation Parameters
   PER(x)17.04115.5819.349.7713.87
   PCE(x)14.9384.4816.467.4611.19
   Price/Book(x)1.353.581.840.480.82
   Yield(%)2.721.071.430.000.00
   EV/Net Sales(x)2.046.802.090.861.16
   EV/Core EBITDA(x)12.6859.3711.486.138.83
   EV/EBIT(x)14.0972.8012.777.1110.03
   EV/CE(x)1.103.001.440.470.73
   M Cap / Sales1.956.642.040.610.91
Growth Ratio
   Net Sales Growth(%)33.53-8.2224.29-8.8327.94
   Core EBITDA Growth(%)87.71-42.2961.38-2.9054.13
   EBIT Growth(%)107.07-47.6468.30-4.9067.81
   PAT Growth(%)166.11-49.97109.20-13.50175.58
   EPS Growth(%)166.11-55.11109.20-13.50175.58
Financial Stability Ratios
   Total Debt/Equity(x)0.070.100.060.200.23
   Current Ratio(x)1.891.981.621.361.44
   Quick Ratio(x)1.421.441.220.871.10
   Interest Cover(x)14.826.479.593.644.18
   Total Debt/Mcap(x)0.050.030.030.420.28

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.